Table 6

Association of adult respiratory symptoms and lung function with maternal smoking in childhood in never smoking men (n = 3043) and women (n = 3582)

MenWomen
Paternal smokingMaternal smokingPaternal smokingMaternal smoking
OR (95% CI)*OR (95% CI)*OR (95% CI)*OR (95% CI)*
Wheeze1.21 (0.96 to 1.50)§0.87 (0.68 to 1.10)§0.93 (0.76 to 1.13)1.21 (0.98 to 1.51)
>3 asthma symptoms1.13 (0.87 to 1.47)0.72 (0.53 to 0.97)‡0.89 (0.72 to 1.10)1.20 (0.95 to 1.52)
Asthma1.08 (0.76 to 1.54)§0.81 (0.54 to 1.23)0.67 (0.49 to 0.91)1.10 (0.78 to 1.55)
Chronic bronchitis1.00 (0.70 to 1.42)1.07 (0.73 to 1.56)0.94 (0.70 to 1.25)1.13 (0.82 to 1.56)
β coeff (95% CI)†β coeff (95% CI)†β coeff (95% CI)†β coeff (95% CI)†
*Odds ratios with 95% confidence intervals as estimated by logistic regression adjusting for age, body mass index, number of siblings, current environmental tobacco smoking, current occupation, and study centre.
†Analysed with adjustment for height, age, weight, weight squared, number of siblings, current environmental tobacco smoking, current occupation, and study centre.
‡Interaction effect by sex, p<0.05.
§Interaction effect by sex, p⩽0.1.
FEV1 (ml)3 (−38 to 43)−2 (−49 to 44)16 (−12 to 44)−25 (−58 to 8)
FVC (ml)15 (−32 to 62)−10 (−64 to 44)5 (−27 to 38)4 (−34 to 41)
FEV1/FVC ratio (%)−0.2 (−0.7 to 0.3)0.1 (−0.4 to 0.7)§0.2 (−0.2 to 0.6)−0.8 (−1.3 to −0.3)
BHR (ECRHS slope)−0.07 (−0.23 to 0.09)0.19 (0.01 to 0.38)0.18 (0.01 to 0.35)0.11 (−0.08 to 0.31)